Roeland, E., Tejani, M. A., Cheung, E., Dincman, T., Lohiya, V., Agarwal, R., Sajid, S., Gabayan, A., Thumar, J. R., Jin, B., Lebedinsky, C., Braendle, E. E., Zuniga, R. M. (2025). A phase 1b dose escalation study of AV-380 (anti-GDF15 monoclonal antibody) in combination with standard-of-care therapy in cancer patients with cachexia.. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2025.43.16_suppl.tps12142